IMRX Earnings
Immuneering Corp
$
3.250
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Immuneering Corp(IMRX) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Immuneering Corp earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency:
Actual
Estimate
Surprise Analysis
| FY2025Q1 | 2025-05-05 | After Hours | -0.41 | -0.42 | -2.44 | - | 0.00 | - | -4.80 | -8.80 |
| FY2024Q4 | 2025-03-20 | After Hours | -0.42 | -0.58 | -38.10 | - | 0.00 | - | +9.09 | +0.61 |
| FY2024Q2 | 2024-08-06 | - | -0.51 | -0.47 | +7.84 | - | - | - | +1.64 | -6.56 |
| FY2024Q1 | 2024-05-07 | - | -0.45 | -0.49 | -8.89 | - | - | - | -5.45 | -3.64 |
| FY2023Q4 | 2024-03-01 | - | -0.48 | -0.52 | -8.33 | - | - | - | -0.81 | +7.74 |
| FY2023Q3 | 2023-11-09 | - | -0.51 | -0.43 | +15.69 | - | - | - | -11.86 | -10.51 |
| FY2023Q2 | 2023-08-03 | - | -0.54 | -0.43 | +20.37 | - | - | - | -4.03 | -6.37 |
| - | 2023-05-04 | - | -0.54 | -0.51 | +5.56 | - | - | - | -8.75 | -18.18 |
| - | 2023-03-06 | - | -0.58 | -0.50 | +13.79 | - | - | - | +1.96 | +47.94 |
| - | 2022-11-10 | - | -0.48 | -0.49 | -2.08 | - | - | - | - | -20.46 |
IMRX Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Immuneering Corp reported performance for FY2025Q1, announced on 2025-05-05. The company achieved an EPS of -0.42, compared to analyst estimates of -0.41 by -2.44% . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a -4.80% one-day change and a -8.80% five-day change following the earnings release. These movements reflect market reaction in Immuneering Corp growth trajectory and strategic initiatives.
IMRX Earnings Forecast
Looking ahead, Immuneering Corp(IMRX) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for have been Go Up by 153.91%, while EPS estimates have been No Change by %. For the upcoming , revenue estimates have been adjusted No Change by % . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Immuneering Corp long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between IMRX's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Stock Price
Go Up
+153.91%
In Past 3 Month
1Y
3Y
5Y
Fiscal Period
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price3.25
IMRX Revenue and EPS Performance: A Historical Perspective
Immuneering Corp revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q1 (2025-05-05,After Hours):
EPS: -0.42 (Actual) vs.-0.41 (Estimate) (-2.44%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -4.80%(1-Day), -8.80%(5-Day)
FY2024Q4 (2025-03-20,After Hours):
EPS: -0.58 (Actual) vs.-0.42 (Estimate) (-38.10%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 9.09%(1-Day), 0.61%(5-Day)
FY2024Q2 (2024-08-06,):
EPS: -0.47 (Actual) vs.-0.51 (Estimate) (7.84%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 1.64%(1-Day), -6.56%(5-Day)
Earnings Reaction
The chart below shows how IMRX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IMRX sees a +10.13% change in stock price 10 days leading up to the earnings, and a +0.21% change 10 days following the report. On the earnings day itself, the stock moves by -2.83%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2025, the stock changed -4.80% on the day following the earnings release and then changed by 21.60% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
No Data
People Also Watch
SOTK
Sono-Tek Corp
3.260
USD
0.00%
OSTX
OS Therapies Inc
1.780
USD
+6.59%
KOSS
Koss Corp
5.360
USD
+0.56%
MDBH
MDB Capital Holdings LLC
3.750
USD
-2.34%
TORO
Toro Corp
2.920
USD
+5.04%
NEUE
NeueHealth Inc
6.750
USD
+1.05%
MATH
Metalpha Technology Holding Ltd
2.820
USD
+2.17%
INUV
Inuvo Inc
3.880
USD
+0.52%
CRT
Cross Timbers Royalty Trust
8.600
USD
+0.58%
AIXI
Xiao-I Corp
1.570
USD
+0.64%
FAQ
What were the key highlights of IMRX’s latest earnings report for FY2025Q1?
IMRX reported its FY2025Q1 earnings on 2025-05-05, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was -0.42, surpassing the expected -0.41 by -2.44% . The stock experienced a -4.8% price change on the earnings day and a -8.8% change over the next five days, reflecting market reactions to the results.
How did IMRX’s stock price react after the FY2025Q1 earnings release?
What are the revenue and EPS estimates for IMRX for undefined?
How does IMRX’s stock price correlate with earnings forecast revisions?
What should investors expect from IMRX’s next earnings report?